Skip to main content
Mark Agulnik, MD, Oncology, Duarte, CA, City of Hope Comprehensive Cancer Center

MarkAgulnikMD

Oncology Duarte, CA

Sarcoma

Professor of Medicine Department of Medicine Oncology of Therapeutics Research City of Hope

Dr. Agulnik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Agulnik's full profile

Already have an account?

  • Office

    Medical Oncology and Therapeutics Research
    1500 East Duarte Road
    Duarte, CA 91010
    Phone+1 626-256-4673
    Fax+1 626-218-8233
  • Is this information wrong?

Summary

  • Mark Agulnik, M.D., is a respected clinician, educator and researcher who specializes in the treatment of sarcomas – head and neck cancer, bone cancer and soft tissue cancers. He joined City of Hope following a distinguished 15-year career at Northwestern University in Chicago where he directed the institution’s Clinical Trials program.

    Dr. Agulnik received his medical degree from Canada’s McGill University and continued his training at Dalhousie University in Nova Scotia, University of Illinois Chicago and University of Toronto.

    The bilingual (English/French) Dr. Agulnik has volunteered his time and skills in both Haiti and Jamaica.

    Winner of more than a dozen awards, Dr. Agulnik says his “calling and passion” is the care of his patients. His desire to balance research and patient care attracted him to City of Hope and its dedication “to making a difference in the lives of people with cancer and to transform the future of health care by turning science into a practical benefit, hope into reality.”

Education & Training

  • University of Toronto
    University of TorontoClinical Research Fellowship, 2004 - 2006
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004
  • Dalhousie University
    Dalhousie UniversityResidency, Internal Medicine, 1999 - 2001
  • Dalhousie University
    Dalhousie UniversityInternship, Internal Medicine, 1998 - 1999
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2001 - 2026
  • CA State Medical License
    CA State Medical License 2020 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • The Royal College of Physicians and Surgeons of CanadaInternal Medicine/Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles
    Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los AngelesMarch 8th, 2022
  • Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (Devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif
    Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (Devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, CalifSeptember 27th, 2021
  • Experts Explain the Staging and Treatment of cSCC
    Experts Explain the Staging and Treatment of cSCCNovember 28th, 2019

Professional Memberships

Hospital Affiliations